Clinical experience with low-dose continuous infusion of furosemide in acute heart failure: Assessment of efficacy and safety

Journal of Cardiovascular Pharmacology and Therapeutics

Volumn 17, Issue 4, 2012, Pages 373-381

  Ng, Tien M H ^a   Hshieh, Shenche ^a   Chan, Cynthia Y ^a   Elkayam, Uri ^b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

administration; furosemide; heart failure; ventricular ejection fraction

Indexed keywords

CREATININE; DIURETIC AGENT; FUROSEMIDE;

ACUTE HEART FAILURE; ADULT; ARTICLE; BODY WEIGHT; CONTINUOUS INFUSION; CREATININE BLOOD LEVEL; DRUG EFFICACY; DRUG SAFETY; FEMALE; GLOMERULUS FILTRATION RATE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; KIDNEY FUNCTION; KIDNEY INJURY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL;

ACUTE KIDNEY INJURY; ADULT; AGED; COHORT STUDIES; DIURETICS; FEMALE; FUROSEMIDE; HEART FAILURE; HEART VENTRICLES; HUMANS; INCIDENCE; INFUSIONS, INTRAVENOUS; INTENSIVE CARE UNITS; KIDNEY; LOS ANGELES; MALE; MIDDLE AGED; RENAL INSUFFICIENCY; RETROSPECTIVE STUDIES; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84868562508     PISSN: 10742484     EISSN: 19404034     Source Type: Journal    
DOI: 10.1177/1074248412446194     Document Type: Article

References (27)

1. Peacock WF, Costanzo MR, De Marco T, et al. Impact of intravenous loop diuretics on outcomes of patients hospitalized with acute decompensated heart failure: insights from the ADHERE registry. Cardiology. 2009 ; 113 (1). 12-19
2. Felker GM, Lee KL, Bull DA, et al. Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med. 2011 ; 364 (9). 797-805
3. Salvador DR, Rey NR, Ramos GC, Punzalan FE. Continuous infusion versus bolus injection of loop diuretics in congestive heart failure. Cochrane Database Syst Rev. 2005 ; (3). CD003178
4. De Bruyne LK. Mechanisms and management of diuretic resistance in congestive heart failure. Postgrad Med J. 2003 ; 79 (931). 268-271
5. Lahav M, Regev A, Ra'anani P, Theodor E. Intermittent administration of furosemide vs continuous infusion preceded by a loading dose for congestive heart failure. Chest. 1992 ; 102 (3). 725-731
6. Brater DC. Pharmacodynamic considerations in the use of diuretics. Annu Rev Pharmacol Toxicol. 1983 ; 23: 45-62
7. Kaojarern S, Day B, Brater DC. The time course of delivery of furosemide into urine: an independent determinant of overall response. Kidney Int. 1982 ; 22 (1). 69-74
8. Branch RA, Roberts CJ, Homeida M, Levine D. Determinants of response to frusemide in normal subjects. Br J Clin Pharmacol. 1977 ; 4 (2). 121-127
9. van Meyel JJ, Smits P, Dormans T, Gerlag PG, Russel FG, Gribnau FW. Continuous infusion of furosemide in the treatment of patients with congestive heart failure and diuretic resistance. J Intern Med. 1994 ; 235 (4). 329-334
10. Allen LA, Turer AT, Dewald T, Stough WG, Cotter G, O'Connor CM. Continuous versus bolus dosing of Furosemide for patients hospitalized for heart failure. Am J Cardiol. 2010 ; 105 (12). 1794-1797
11. Thomson MR, Nappi JM, Dunn SP, Hollis IB, Rodgers JE, Van Bakel AB. Continuous versus intermittent infusion of furosemide in acute decompensated heart failure. J Card Fail. 2010 ; 16 (3). 188-193
12. Maurer MS, King DL, El-Khoury Rumbarger L, Packer M, Burkhoff D. Left heart failure with a normal ejection fraction: identification of different pathophysiologic mechanisms. J Card Fail. 2005 ; 11 (3). 177-187
13. Fontes-Carvalho R, Leite-Moreira A. Heart failure with preserved ejection fraction: fighting misconceptions for a new approach. Arq Bras Cardiol. 2011 ; 96 (6). 504-514
14. Dormans TP, van Meyel JJ, Gerlag PG, Tan Y, Russel FG, Smits P. Diuretic efficacy of high dose furosemide in severe heart failure: bolus injection versus continuous infusion. J Am Coll Cardiol. 1996 ; 28 (2). 376-382
15. Kramer WG, Smith WB, Ferguson J, et al. Pharmacodynamics of torsemide administered as an intravenous injection and as a continuous infusion to patients with congestive heart failure. J Clin Pharmacol. 1996 ; 36 (3). 265-270
16. Aaser E, Gullestad L, Tollofsrud S, et al. Effect of bolus injection versus continuous infusion of furosemide on diuresis and neurohormonal activation in patients with severe congestive heart failure. Scand J Clin Lab Invest. 1997 ; 57 (4). 361-367
17. Forman DE, Butler J, Wang Y, et al. Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure. J Am Coll Cardiol. 2004 ; 43 (1). 61-67
18. Heywood JT, Fonarow GC, Costanzo MR, Mathur VS, Wigneswaran JR, Wynne J. High prevalence of renal dysfunction and its impact on outcome in 118,465 patients hospitalized with acute decompensated heart failure: a report from the ADHERE database. J Card Fail. 2007 ; 13 (6). 422-430
19. Hillege HL, Girbes AR, de Kam PJ, et al. Renal function, neurohormonal activation, and survival in patients with chronic heart failure. Circulation. 2000 ; 102 (2). 203-210
20. Gottlieb SS, Abraham W, Butler J, et al. The prognostic importance of different definitions of worsening renal function in congestive heart failure. J Card Fail. 2002 ; 8 (3). 136-141
21. Yip GW, Wang M, Wang T, et al. The Hong Kong diastolic heart failure study: a randomised controlled trial of diuretics, irbesartan and ramipril on quality of life, exercise capacity, left ventricular global and regional function in heart failure with a normal ejection fraction. Heart. 2008 ; 94 (5). 573-580
22. Parissis JT, Ikonomidis I, Rafouli-Stergiou P, et al. Clinical characteristics and predictors of in-hospital mortality in acute heart failure with preserved left ventricular ejection fraction. Am J Cardiol. 2011 ; 107 (1). 79-84
23. Yancy CW, Lopatin M, Stevenson LW, De Marco T, Fonarow GC. Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database. J Am Coll Cardiol. 2006 ; 47 (1). 76-84
24. Wargo KA, Banta WM. A comprehensive review of the loop diuretics: should furosemide be first line?. Ann Pharmacother. 2009 ; 43 (11). 1836-1847
25. Murray MD, Deer MM, Ferguson JA, et al. Open-label randomized trial of torsemide compared with furosemide therapy for patients with heart failure. Am J Med. 2001 ; 111 (7). 513-520
26. Muller K, Gamba G, Jaquet F, Hess B. Torasemide vs. furosemide in primary care patients with chronic heart failure NYHA II to IV-efficacy and quality of life. Eur J Heart Fail. 2003 ; 5 (6). 793-801
27. Cosin J, Diez J. Torasemide in chronic heart failure: results of the TORIC study. Eur J Heart Fail. 2002 ; 4 (4). 507-513